SAHPRA PAVES WAY FOR LENACAPAVIR
Wed 29 October 2025: South Africa has become the first country in Africa to register lenacapavir, a twice-a-year anti-HIV injection. The South African Health Products Regulatory Authority (SAHPRA) announced the approval, marking a significant milestone in the country’s ongoing efforts to curb new HIV infections. In March 2025, US-based biopharmaceutical company Gilead applied to SAHPRA […]
Continue Reading
